View Older Stories View More Recent Stories

May 4, 2026 05:54AM Evotec nominates preclinical candidate from dermatology partnership
May 4, 2026 01:50AM Evotec Announces Nomination of First Preclinical Development Candidate in Dermatology Collaboration with Almirall
Apr 30, 2026 05:22AM Evotec SE (EVO) Receives Grants to Advance Tuberculosis Treatment
Apr 30, 2026 03:20AM Evotec Receives Grants to Advance Tuberculosis Treatment
Apr 29, 2026 04:45PM Evotec nominates Dr. Wolfgang Hofmann to supervisory board
Apr 29, 2026 04:45PM Evotec Announces New Nomination to Board of Directors
Apr 29, 2026 01:50AM Evotec SE to Announce First Quarter 2026 Results on May 6, 2026
Apr 24, 2026 01:50AM Evotec names Claire Hinshelwood as new CFO, replacing Paul Hitchin
Apr 24, 2026 01:50AM Evotec Announces Chief Financial Officer Transition
Apr 15, 2026 01:50AM Evotec appoints Dr. Ingrid Müller as chief operating officer
Apr 15, 2026 01:50AM Evotec Appoints Dr. Ingrid Müller as Chief Operating Officer
Apr 7, 2026 03:57AM Evotec nominates Dieter Weinand as supervisory board chairman
Apr 7, 2026 03:00AM Evotec Nominates Dieter Weinand as Supervisory Board Chairman
Apr 1, 2026 05:35AM Evotec SE to Announce Fourth Quarter and Full-Year 2025 Results on April 8, 2026
Apr 1, 2026 01:50AM Evotec names Dr. Ashiq Khan as chief commercial officer
Apr 1, 2026 01:50AM Evotec Appoints Dr. Ashiq H. Khan as Chief Commercial Officer
Mar 23, 2026 03:10AM Just - Evotec Biologics Enters Project Agreement with BARDA to Optimize Biomanufacturing of Antibodies Against Ebola and Related Viruses
Mar 19, 2026 02:50AM Evotec Receives $10 M Milestone from Bristol Myers Squibb Protein Degradation Collaboration for Clinical Study Initiation
Jan 8, 2026 01:50AM Just - Evotec Biologics Receives Grant for AI-Driven Optimization of Monoclonal Antibody Developability for Affordable Access
Jan 2, 2026 12:30AM Evotec Appoints Dr. Sarah Fakih as EVP, Head of Global Communications and Investor Relations
Oct 27, 2025 04:40AM Evotec receives $25 million from Bristol Myers Squibb for neuroscience work
Dec 11, 2024 02:00AM Evotec SE announces first projects for LAB eN(2) drug discovery accelerator with Novo Nordisk
Nov 22, 2024 08:35AM Halozyme Therapeutics (HALO) Withdraws Proposal to Acquire Evotec (EVO) Following Evotec's Unwillingness to Engage in Discussions
Nov 22, 2024 08:35AM Halozyme Withdraws Proposal to Acquire Evotec Following Evotec's Unwillingness to Engage in Discussions
Nov 18, 2024 07:03AM Halozyme Therapeutics (HALO) Provides Update on Non-Binding Proposal to Combine with Evotec (EVO)
Nov 18, 2024 07:00AM Halozyme Provides Update on Non-Binding Proposal to Combine with Evotec
Nov 14, 2024 04:16PM Halozyme Therapeutics (HALO) Confirms Proposal to Combine with Evotec (EVO) for €11.00 Per Share in an All-Cash Transaction
Nov 14, 2024 04:15PM Halozyme Confirms Proposal to Combine with Evotec for €11.00 Per Share in an All-Cash Transaction
Nov 6, 2024 01:20AM Evotec SE Reports 9M 2024 Results: Strategic Progress and Successful Expansion Amid Challenging Market Conditions
Nov 5, 2024 01:50AM Evotec Announces Sale of API Manufacturing Facility to Monacum Partners
Oct 30, 2024 03:30AM Evotec SE to Announce Results for the First Nine Months 2024 on 06 November 2024
Oct 23, 2024 02:00AM Evotec and Bristol Myers Squibb Expand Proteomics Partnership
Sep 20, 2024 09:45AM Just - Evotec Biologics Opens Cutting-Edge Biologics Facility - J.POD(R) Toulouse, France (EU)
Sep 3, 2024 01:50AM Evotec Announces Change in Management Board
Jul 10, 2024 05:22AM Evotec SE (EVO) and Pfizer Collaborate to Advance Drug Discovery in France
Jul 10, 2024 01:50AM Evotec and Pfizer Collaborate to Advance Drug Discovery in France
Jul 8, 2024 08:20AM Just - Evotec Biologics Expands Tech Partnership for Biosimilars with Sandoz
Jun 10, 2024 12:15PM Evotec SE: Results of the Annual General Meeting 2024
May 14, 2024 08:34AM Centogene N.V. (CNTG) and Evotec (EVO) Discover Promising New Molecule to Treat Gaucher Disease
May 14, 2024 08:30AM CENTOGENE and Evotec Discover Promising New Molecule to Treat Gaucher Disease
Apr 18, 2024 07:27AM Evotec (EVO) And Variant Bio Enter Strategic Partnership To Discover And Develop Fibrosis Treatments
Apr 18, 2024 07:27AM EVOTEC AND VARIANT BIO ENTER STRATEGIC PARTNERSHIP TO DISCOVER AND DEVELOP FIBROSIS TREATMENTS
Dec 6, 2023 01:50AM Evotec-partner Jingxin Receives Approval for EVT201 in China
Nov 7, 2023 01:30AM Dewpoint Therapeutics Enters Strategic Partnership with Evotec to Accelerate Oncology Pipeline
May 16, 2023 09:00AM Galaxy Gaming® and Evolution Extend Licensing Agreement for 10 Years
May 9, 2023 02:30PM Just - Evotec Biologics Launches Tech Partnership for Biosimilars Development and Commercial Manufacturing
Apr 11, 2023 08:30AM RenovoRx Appoints Leesa Gentry as Senior Vice President of Clinical Operations
Mar 28, 2023 01:30AM Evotec SE Preliminary Fiscal Year 2022 Results: 'Ahead of the Curve' - Very Strong Performance in a Challenging Year
Mar 21, 2023 07:10AM Evotec SE to Announce Preliminary Financial Results for Fiscal Year 2022 on 28 March 2023
Mar 16, 2023 05:49AM Evotec SE (EVO) Reports on Progress in Strategic Protein Degradation Partnership with Bristol Myers Squibb
View More Recent Stories View Older Stories